Loss of p53 suppresses replication stress-induced DNA damage in ATRX-deficient neuroblastoma
Abstract Genetic aberrations are present in the ATRX gene in older high-risk neuroblastoma (NB) patients with very poor clinical outcomes. Its loss-of-function (LoF) facilitates the alternative lengthening of telomeres (ALT) pathway in tumor cells and is strongly linked to replication stress (RS) an...
Enregistré dans:
Auteurs principaux: | Jesmin Akter, Yutaka Katai, Parvin Sultana, Hisanori Takenobu, Masayuki Haruta, Ryuichi P. Sugino, Kyosuke Mukae, Shunpei Satoh, Tomoko Wada, Miki Ohira, Kiyohiro Ando, Takehiko Kamijo |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Publishing Group
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a2daa5a4a53642579e6bb90d160a40c5 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
MYCN amplification and ATRX mutations are incompatible in neuroblastoma
par: Maged Zeineldin, et autres
Publié: (2020) -
Disruption of ATRX-RNA interactions uncovers roles in ATRX localization and PRC2 function
par: Wenqing Ren, et autres
Publié: (2020) -
Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX
par: Alexandre de Nonneville, et autres
Publié: (2021) -
ATRX is a regulator of therapy induced senescence in human cells
par: Marta Kovatcheva, et autres
Publié: (2017) -
Formal reply to “Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX”
par: Lars Feuerbach
Publié: (2021)